• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Epidemiol Infect . Surveillance of SARS-CoV-2 prevalence from repeated pooled testing: application to Swiss routine data

tetano

Editor, Senior Moderator
Epidemiol Infect


. 2024 Aug 22:152:e100.
doi: 10.1017/S0950268824000876. Surveillance of SARS-CoV-2 prevalence from repeated pooled testing: application to Swiss routine data

Julien Riou[SUP] 1 2 [/SUP], Erik Studer[SUP] 3 [/SUP], Anna Fesser[SUP] 3 [/SUP], Tobias Magnus Schuster[SUP] 3 [/SUP], Nicola Low[SUP] 1 [/SUP], Matthias Egger[SUP] 1 4 5 [/SUP], Anthony Hauser[SUP] 1 6 [/SUP]



Affiliations
Abstract

Surveillance of SARS-CoV-2 through reported positive RT-PCR tests is biased due to non-random testing. Prevalence estimation in population-based samples corrects for this bias. Within this context, the pooled testing design offers many advantages, but several challenges remain with regards to the analysis of such data. We developed a Bayesian model aimed at estimating the prevalence of infection from repeated pooled testing data while (i) correcting for test sensitivity; (ii) propagating the uncertainty in test sensitivity; and (iii) including correlation over time and space. We validated the model in simulated scenarios, showing that the model is reliable when the sample size is at least 500, the pool size below 20, and the true prevalence below 5%. We applied the model to 1.49 million pooled tests collected in Switzerland in 2021-2022 in schools, care centres, and workplaces. We identified similar dynamics in all three settings, with prevalence peaking at 4-5% during winter 2022. We also identified differences across regions. Prevalence estimates in schools were correlated with reported cases, hospitalizations, and deaths (coefficient 0.84 to 0.90). We conclude that in many practical situations, the pooled test design is a reliable and affordable alternative for the surveillance of SARS-CoV-2 and other viruses.

Keywords: SARS-CoV-2; epidemics; screening programme; surveillance.

 
Back
Top Bottom